FRESENIUS MEDICAL CARE AG (FME.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:FME - DE0005785802 - Common Stock
37.34 EUR
+0.41 (+1.11%)
FME gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 32 industry peers in the Health Care Providers & Services industry. FME has only an average score on both its financial health and profitability. FME is valued quite cheap, while showing a decent growth score. This is a good combination! FME also has an excellent dividend rating. These ratings could make FME a good candidate for value and dividend investing.
1. Profitability
1.1 Basic Checks
- FME had positive earnings in the past year.
- FME had a positive operating cash flow in the past year.
- Each year in the past 5 years FME has been profitable.
- In the past 5 years FME always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 2.33%, FME is in line with its industry, outperforming 46.88% of the companies in the same industry.
- FME has a Return On Equity (5.55%) which is comparable to the rest of the industry.
- FME has a Return On Invested Capital (3.95%) which is in line with its industry peers.
- FME had an Average Return On Invested Capital over the past 3 years of 3.14%. This is below the industry average of 7.02%.
- The last Return On Invested Capital (3.95%) for FME is above the 3 year average (3.14%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROIC | 3.95% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
- FME has a Profit Margin of 3.66%. This is in the better half of the industry: FME outperforms 68.75% of its industry peers.
- FME's Profit Margin has declined in the last couple of years.
- With a decent Operating Margin value of 7.19%, FME is doing good in the industry, outperforming 68.75% of the companies in the same industry.
- In the last couple of years the Operating Margin of FME has declined.
- FME's Gross Margin of 25.00% is fine compared to the rest of the industry. FME outperforms 65.63% of its industry peers.
- FME's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FME is destroying value.
- Compared to 1 year ago, FME has about the same amount of shares outstanding.
- Compared to 5 years ago, FME has less shares outstanding
- FME has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 2.13 indicates that FME is not a great score, but indicates only limited risk for bankruptcy at the moment.
- FME has a Altman-Z score (2.13) which is comparable to the rest of the industry.
- FME has a debt to FCF ratio of 5.97. This is a neutral value as FME would need 5.97 years to pay back of all of its debts.
- FME has a Debt to FCF ratio of 5.97. This is in the better half of the industry: FME outperforms 68.75% of its industry peers.
- A Debt/Equity ratio of 0.73 indicates that FME is somewhat dependend on debt financing.
- FME's Debt to Equity ratio of 0.73 is fine compared to the rest of the industry. FME outperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Altman-Z | 2.13 |
ROIC/WACC0.71
WACC5.58%
2.3 Liquidity
- A Current Ratio of 1.36 indicates that FME should not have too much problems paying its short term obligations.
- FME has a Current ratio of 1.36. This is in the better half of the industry: FME outperforms 71.88% of its industry peers.
- FME has a Quick Ratio of 1.36. This is a bad value and indicates that FME is not financially healthy enough and could expect problems in meeting its short term obligations.
- FME has a Quick ratio of 1.00. This is in the better half of the industry: FME outperforms 65.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
- FME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.77%, which is quite good.
- FME shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.43% yearly.
- FME shows a small growth in Revenue. In the last year, the Revenue has grown by 2.10%.
- The Revenue has been growing slightly by 2.04% on average over the past years.
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
3.2 Future
- The Earnings Per Share is expected to grow by 12.37% on average over the next years. This is quite good.
- FME is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.81% yearly.
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y12.37%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y3.81%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- FME is valuated reasonably with a Price/Earnings ratio of 9.93.
- Based on the Price/Earnings ratio, FME is valued cheaply inside the industry as 90.63% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Earnings ratio of 27.54, FME is valued rather cheaply.
- A Price/Forward Earnings ratio of 9.00 indicates a reasonable valuation of FME.
- Based on the Price/Forward Earnings ratio, FME is valued cheaply inside the industry as 90.63% of the companies are valued more expensively.
- The average S&P500 Price/Forward Earnings ratio is at 24.31. FME is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.93 | ||
| Fwd PE | 9 |
4.2 Price Multiples
- FME's Enterprise Value to EBITDA ratio is in line with the industry average.
- Based on the Price/Free Cash Flow ratio, FME is valued a bit cheaper than 62.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.49 | ||
| EV/EBITDA | 9.85 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- FME's earnings are expected to grow with 13.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.46
PEG (5Y)N/A
EPS Next 2Y12.96%
EPS Next 3Y13.16%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 3.69%, FME has a reasonable but not impressive dividend return.
- In the last 3 months the price of FME has falen by -20.41%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
- FME's Dividend Yield is rather good when compared to the industry average which is at 1.57. FME pays more dividend than 96.88% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.92, FME pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.69% |
5.2 History
- The dividend of FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
- FME pays out 58.83% of its income as dividend. This is a bit on the high side, but may be sustainable.
- FME's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.83%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
FRA:FME (1/16/2026, 9:38:56 AM)
37.34
+0.41 (+1.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-24 2026-02-24/amc
Inst Owners43.91%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap21.91B
Revenue(TTM)19.64B
Net Income(TTM)718.19M
Analysts57.86
Price Target47.6 (27.48%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.69% |
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP58.83%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.52%
Min EPS beat(2)14.16%
Max EPS beat(2)14.89%
EPS beat(4)4
Avg EPS beat(4)17.81%
Min EPS beat(4)14.16%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)16.37%
EPS beat(12)10
Avg EPS beat(12)13.79%
EPS beat(16)12
Avg EPS beat(16)10.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-1.71%
Revenue beat(4)2
Avg Revenue beat(4)0.94%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-0.53%
PT rev (3m)-5.45%
EPS NQ rev (1m)2.82%
EPS NQ rev (3m)-3.65%
EPS NY rev (1m)0.17%
EPS NY rev (3m)3.37%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)1.16%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.93 | ||
| Fwd PE | 9 | ||
| P/S | 1.12 | ||
| P/FCF | 12.49 | ||
| P/OCF | 8.73 | ||
| P/B | 1.69 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.85 |
EPS(TTM)3.76
EY10.07%
EPS(NY)4.15
Fwd EY11.11%
FCF(TTM)2.99
FCFY8.01%
OCF(TTM)4.28
OCFY11.46%
SpS33.47
BVpS22.07
TBVpS-3.21
PEG (NY)0.46
PEG (5Y)N/A
Graham Number43.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROCE | 5.62% | ||
| ROIC | 3.95% | ||
| ROICexc | 4.26% | ||
| ROICexgc | 11.65% | ||
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% | ||
| FCFM | 8.93% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score5
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Debt/EBITDA | 3.12 | ||
| Cap/Depr | 47.15% | ||
| Cap/Sales | 3.85% | ||
| Interest Coverage | 3.87 | ||
| Cash Conversion | 83.24% | ||
| Profit Quality | 244.33% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.13 |
F-Score5
WACC5.58%
ROIC/WACC0.71
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y12.37%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y3.81%
EBIT growth 1Y-3.43%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.22%
EBIT Next 3Y29.78%
EBIT Next 5Y18.33%
FCF growth 1Y-5.89%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y0.06%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%
FRESENIUS MEDICAL CARE AG / FME.DE FAQ
What is the fundamental rating for FME stock?
ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.
What is the valuation status for FME stock?
ChartMill assigns a valuation rating of 7 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Undervalued.
Can you provide the profitability details for FRESENIUS MEDICAL CARE AG?
FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 5 / 10.
What is the valuation of FRESENIUS MEDICAL CARE AG based on its PE and PB ratios?
The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 9.93 and the Price/Book (PB) ratio is 1.69.
How sustainable is the dividend of FRESENIUS MEDICAL CARE AG (FME.DE) stock?
The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 7 / 10 and the dividend payout ratio is 58.83%.